Expert-Led Advisory · Evidara

Evidence analysis,
expertly guided.

We run Evidara's full evidence platform on your behalf — delivering structured, audit-ready outputs for HEOR, market access, and regulatory decision-making. Fixed scope. Fixed price. Delivered in days, not months.

Who this is for

Pharmaceutical teams that need evidence faster.

Advisory engagements are fixed scope and fixed price. A deliverable at the end — not a retainer or a kickoff meeting.

Biotech & Specialty Pharma

Evidence packages without the in-house headcount

Early-stage teams building first-in-class payer evidence or preparing pre-NDA submissions — without the resources to run full systematic reviews internally.

Integrated Pharma · HEOR

Faster time to evidence, same rigour

HEOR and medical affairs groups that need structured evidence packages — SLRs, GRADE tables, ICER benchmarking — delivered in working days rather than months.

Health Economics Consultancies

Evidence acceleration for client engagements

Agency teams running HEOR engagements who need to compress evidence gathering from weeks to days — without compromising on source provenance or audit quality.

Services & Pricing

Fixed scope. Fixed price. Delivered in days.

All engagements use Evidara's 30+ agent platform, 16 live databases, and 21 CFR Part 11 audit trail. Findings carry source provenance — PMID, NCT ID, or NDA number — and anything unsourced is flagged for review.

Rapid Evidence Brief

Specific question answered with expert review

One focused clinical question — rapid SLR, evidence table with PMID citations, GRADE quality assessment, and human expert review. Ideal for first engagement or pre-meeting preparation.

$3,500
per engagement
  • 1 clinical question, PICO-framed
  • Rapid SLR across PubMed & Europe PMC
  • Evidence table with PMID citations
  • GRADE quality assessment
  • Human expert review
  • PDF delivery
3 business days · Fixed scope
Book a consultation →
Strategic Retainer

Ongoing medical affairs or market access support

Two full dossiers per month, 48-hour priority rapid briefs, monthly strategy session, and quarterly evidence updates on tracked assets. Built for continuous evidence needs.

$6,500
per month · 3-month minimum
  • 2 full dossiers per month
  • Priority 48hr rapid briefs
  • Monthly strategy session
  • Quarterly evidence updates on tracked assets
  • Dedicated support
3-month minimum · Additional dossiers $7,000 · Rapid briefs $2,500
Book a consultation →

How pricing works: Start with a Rapid Evidence Brief to see what Evidara Advisory delivers for your specific asset. Most clients move to Full Dossier or Strategic Retainer after their first engagement.

All Advisory engagements include: human expert review by PhD MHA founder, full source citations (PMID / NCT ID / FDA NDA number), GRADE evidence quality assessment, evidence classification labels on every finding, governance notice (suitable for regulatory context), PDF delivery formatted for payer or HTA submission. Association is never presented as causation.

How Advisory works

From brief to audit-ready PDF in 3–7 days.

Every engagement follows the same rigorous process. Fixed price confirmed before any work begins.

Day 1

You brief us

You share the indication, compound, and clinical question. We confirm scope, deliverable format, and fixed price before work begins.

Day 1–2

Platform synthesis

Evidara OS synthesizes evidence across 16 databases and 30+ AI agents using PRISMA methodology — all findings sourced to PMID, NCT ID, or NDA number.

Day 2–5

Expert review

Our PhD MHA founder reviews, frames, and quality-checks every finding against primary source documents. Evidence classification labels assigned to every claim.

Day 3–7

Delivery

You receive a human-reviewed, audit-ready PDF with full PMID / NCT citations, governance notice, and GRADE assessment. Suitable for regulatory context.

What's included in every engagement

Expert-reviewed. Audit-ready. Cited to source.

Human expert review by PhD MHA founder
Full source citations (PMID / NCT ID / FDA NDA number)
GRADE evidence quality assessment
Evidence classification labels on every finding
Governance notice (suitable for regulatory context)
PDF delivery formatted for payer or HTA submission
Association never presented as causation
Fixed price confirmed before work begins
Frequently asked

Questions about Advisory.

How is Advisory different from the platform?
Advisory includes expert human review, framing, and quality assurance of every output by our PhD MHA founder. The platform is self-serve. Advisory is the right choice when the output will be used in a payer meeting, HTA submission, or regulatory context.
Can I start with a Rapid Evidence Brief and upgrade?
Yes. Most clients start with a Rapid Evidence Brief to see what Evidara Advisory delivers for their specific asset, then move to Full Dossier or Strategic Retainer.
Is there a discount for multiple Advisory engagements?
Yes. The Strategic Retainer at $6,500/month includes 2 full dossiers — effectively $3,250 each versus $9,500 standalone. Retainer clients also get priority 48-hour turnaround on rapid briefs.
What does "human expert review" mean exactly?
Every finding is reviewed against the primary source document — not just the AI synthesis. Evidence classification labels are verified. Governance language is checked. Where evidence is contradictory or sparse, this is named explicitly rather than smoothed over.
How do I get started?
Email celldna1@gmail.com with your indication, compound, and the clinical question you need answered. We'll respond within one business day with scope and fixed price confirmation.
What every engagement includes

Audit-ready by construction.

Source Provenance
Every finding is checked against its primary source before delivery, and anything unsourced is flagged and resolved. Associative signals are labeled as such — never upgraded to causal inference.
21 CFR Part 11 Audit Trail
Every analysis is logged with agent identities, input and output hashes, and user identity. Append-only schema. HMAC-signed per entry. Tamper-evident by construction.
Human Review Flags
Where evidence is contradictory, sparse, or below GRADE threshold, outputs are flagged for human review — never silently synthesized away.
Building internal AI capability beyond pharma? See Evidara Intelligence — AI architecture consulting →
Start a project

Ready to begin?
Let's talk scope.

Most engagements start with a 30-minute brief. We'll confirm scope, deliverable format, and timeline — fixed price before we start.